Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1993 Nov;80(3):395–400.

Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin.

M R Young 1, J L Kut 1, M P Coogan 1, M A Wright 1, M E Young 1, J Matthews 1
PMCID: PMC1422219  PMID: 8288316

Abstract

The modulatory effects of endogenous serotonin on splenic T-cell activity were investigated using two distinct approaches. The first approach showed that pretreatment of mice with p-cholorphenylalanine (PCPA) to deplete intracellular stores of serotonin reduced the capacity of their splenic T cells to proliferate and to express interleukin-2 receptor (IL-2R) in response to concanavalin A (Con A). These responses could be restored by the addition of serotonin to the spleen cell cultures. In contrast, PCPA treatment did not effect stimulation of spleen cells to produce IL-2. The second approach showed that T-cell proliferation to Con A as well as to IL-2 was diminished by the presence of antagonists to the serotonin-2 receptor (5-HT2R). The effects of low doses (100 ng/ml) of exogenously added serotonin on functions of normal spleen cells were also examined. At this low dose, serotonin stimulated splenic T-cell proliferation in response to IL-2, and enhanced both proliferation and IL-2 production in response to a suboptimal concentration of Con A. These results show autologous serotonin to be required for T-cell activation and that the activation of suboptimally stimulated T cells can be augmented with low doses of exogenously added serotonin. These data also suggest that the positive regulation of T-cell function by serotonin is mediated through 5-HT2R.

Full text

PDF
395

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ader R., Felten D., Cohen N. Interactions between the brain and the immune system. Annu Rev Pharmacol Toxicol. 1990;30:561–602. doi: 10.1146/annurev.pa.30.040190.003021. [DOI] [PubMed] [Google Scholar]
  2. Ameisen J. C., Meade R., Askenase P. W. A new interpretation of the involvement of serotonin in delayed-type hypersensitivity. Serotonin-2 receptor antagonists inhibit contact sensitivity by an effect on T cells. J Immunol. 1989 May 1;142(9):3171–3179. [PubMed] [Google Scholar]
  3. Aune T. M., Kelley K. A., Ranges G. E., Bombara M. P. Serotonin-activated signal transduction via serotonin receptors on Jurkat cells. J Immunol. 1990 Sep 15;145(6):1826–1831. [PubMed] [Google Scholar]
  4. Carlson S. L., Felten D. L., Livnat S., Felten S. Y. Alterations of monoamines in specific central autonomic nuclei following immunization in mice. Brain Behav Immun. 1987 Mar;1(1):52–63. doi: 10.1016/0889-1591(87)90006-7. [DOI] [PubMed] [Google Scholar]
  5. Casey L. S., Lichtman A. H., Boothby M. IL-4 induces IL-2 receptor p75 beta-chain gene expression and IL-2-dependent proliferation in mouse T lymphocytes. J Immunol. 1992 Jun 1;148(11):3418–3426. [PubMed] [Google Scholar]
  6. Devoino L., Morozova N., Cheido M. Participation of serotoninergic system in neuroimmunomodulation: intraimmune mechanisms and the pathways providing an inhibitory effect. Int J Neurosci. 1988 May;40(1-2):111–128. doi: 10.3109/00207458808985733. [DOI] [PubMed] [Google Scholar]
  7. Fuchs B. A., Campbell K. S., Munson A. E. Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte beta-adrenergic receptor density and the humoral immune response in vivo and in vitro. Cell Immunol. 1988 Dec;117(2):339–351. doi: 10.1016/0008-8749(88)90123-2. [DOI] [PubMed] [Google Scholar]
  8. Garssen J., Nijkamp F. P., Wagenaar S. S., Zwart A., Askenase P. W., Van Loveren H. Regulation of delayed-type hypersensitivity-like responses in the mouse lung, determined with histological procedures: serotonin, T-cell suppressor-inducer factor and high antigen dose tolerance regulate the magnitude of T-cell dependent inflammatory reactions. Immunology. 1989 Sep;68(1):51–58. [PMC free article] [PubMed] [Google Scholar]
  9. Hellstrand K., Hermodsson S. Enhancement of human natural killer cell cytotoxicity by serotonin: role of non-T/CD16+ NK cells, accessory monocytes, and 5-HT1A receptors. Cell Immunol. 1990 Apr 15;127(1):199–214. doi: 10.1016/0008-8749(90)90125-b. [DOI] [PubMed] [Google Scholar]
  10. Hellstrand K., Hermodsson S. Monocyte-mediated suppression of IL-2-induced NK-cell activation. Regulation by 5-HT1A-type serotonin receptors. Scand J Immunol. 1990 Aug;32(2):183–192. doi: 10.1111/j.1365-3083.1990.tb02908.x. [DOI] [PubMed] [Google Scholar]
  11. Henley W. N., Bellush L. L. Streptozotocin-induced decreases in serotonin turnover are prevented by thyroidectomy. Neuroendocrinology. 1992 Sep;56(3):354–363. doi: 10.1159/000126249. [DOI] [PubMed] [Google Scholar]
  12. Kut J. L., Young M. R., Crayton J. W., Wright M. A., Young M. E. Regulation of murine T-lymphocyte function by spleen cell-derived and exogenous serotonin. Immunopharmacol Immunotoxicol. 1992;14(4):783–796. doi: 10.3109/08923979209009235. [DOI] [PubMed] [Google Scholar]
  13. LeFever A., Liepins A., Truitt R. Role of K+ ion channels in lymphokine-activated killer (LAK) cell lytic function. Immunopharmacol Immunotoxicol. 1989;11(4):571–582. doi: 10.3109/08923978909005386. [DOI] [PubMed] [Google Scholar]
  14. Los G., De Weger R. A., Van den Berg D. T., Sakkers R., Den Otter W. Macrophage infiltration in tumors and tumor-surrounding tissue: influence of serotonin and sensitized lymphocytes. Cancer Immunol Immunother. 1988;26(2):145–152. doi: 10.1007/BF00205608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Neveu P. J., Le Moal M. Physiological basis for neuroimmunomodulation. Fundam Clin Pharmacol. 1990;4(3):281–305. doi: 10.1111/j.1472-8206.1990.tb00496.x. [DOI] [PubMed] [Google Scholar]
  16. Przegaliński E., Jaworska L., Gołembiowska K. The effect of p-chloroamphetamine and p-chlorophenylalanine on the level of thyrotropin-releasing hormone and its receptors in some brain structures and lumbar spinal cord of the rat. Neuropeptides. 1992 Sep;23(1):19–25. doi: 10.1016/0143-4179(92)90005-h. [DOI] [PubMed] [Google Scholar]
  17. Roberts D., Katz D. R., Mukherjee S., Rook G. A. Induction of delayed-type hypersensitivity responses to PPD: dendritic cells in synergy with 5-hydroxytryptamine can substitute for macrophages. Immunology. 1988 Apr;63(4):697–700. [PMC free article] [PubMed] [Google Scholar]
  18. Roth B. L., Ciaranello R. D. Chronic mianserin treatment decreases 5-HT2 receptor binding without altering 5-HT2 receptor mRNA levels. Eur J Pharmacol. 1991 Jun 19;207(2):169–172. doi: 10.1016/0922-4106(91)90093-w. [DOI] [PubMed] [Google Scholar]
  19. Van de Kar L. D. Neuroendocrine aspects of the serotonergic hypothesis of depression. Neurosci Biobehav Rev. 1989 Winter;13(4):237–246. doi: 10.1016/s0149-7634(89)80056-9. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES